ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

0.2725
-0.0841
(-23.58%)
Cerrado 18 Abril 3:00PM
0.27
-0.0025
(-0.92%)
Fuera de horario: 6:58PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.27
Postura de Compra
0.263
Postura de Venta
0.27
Volume Operado de la Acción
5,689,080
0.219565 Rango del Día 0.3577
0.26 Rango de 52 semanas 66.33
Capitalización de Mercado [m]
Precio Anterior
0.3566
Precio de Apertura
0.3507
Última hora de negociación
Volumen financiero
US$ 1,672,571
Precio Promedio Ponderado
0.293997
Volumen promedio (3 m)
7,690,999
Acciones en circulación
23,341,336
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.34
Beneficio por acción (BPA)
-0.79
turnover
-
Beneficio neto
-18.55M

Acerca de TransCode Therapeutics Inc

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-
TransCode Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAZ. The last closing price for TransCode Therapeutics was US$0.36. Over the last year, TransCode Therapeutics shares have traded in a share price range of US$ 0.26 to US$ 66.33.

TransCode Therapeutics currently has 23,341,336 shares in issue. The market capitalisation of TransCode Therapeutics is US$8.32 million. TransCode Therapeutics has a price to earnings ratio (PE ratio) of -0.34.

RNAZ Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.12-30.76923076920.390.41990.2617260110.38965842CS
4-0.5115-65.45105566220.78151.670.26154254070.94339834CS
12-6.25-95.85889570556.5216.730.2676909992.60716328CS
26-22.335-98.805573988122.60525.410.2638221743.17710676CS
52-16.8537-98.423237968417.123766.330.2627330498.89331391CS
156-76559.73-99.99964733547656079762.320.2620986194810.11131127CS
260-158399.73-99.99982954551584001848000.26198738021316.6021351CS

RNAZ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de TransCode Therapeutics?
El precio actual de las acciones de TransCode Therapeutics es US$ 0.27
¿Cuántas acciones de TransCode Therapeutics están en circulación?
TransCode Therapeutics tiene 23,341,336 acciones en circulación
¿Cuál es la capitalización de mercado de TransCode Therapeutics?
La capitalización de mercado de TransCode Therapeutics es USD 8.32M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de TransCode Therapeutics?
TransCode Therapeutics ha negociado en un rango de US$ 0.26 a US$ 66.33 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de TransCode Therapeutics?
El ratio precio/beneficio de TransCode Therapeutics es -0.34
¿Cuál es la moneda de reporte de TransCode Therapeutics?
TransCode Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de TransCode Therapeutics?
El último beneficio anual de TransCode Therapeutics es USD -18.55M
¿Cuál es la dirección registrada de TransCode Therapeutics?
La dirección registrada de TransCode Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de TransCode Therapeutics?
La dirección del sitio web de TransCode Therapeutics es www.transcodetherapeutics.com
¿En qué sector industrial opera TransCode Therapeutics?
TransCode Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MSGMMotorsport Games Inc
US$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
US$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
US$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
US$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
US$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
US$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
US$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
US$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
US$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
US$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
US$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
US$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
US$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
US$ 8.205
(43.70%)
266.91M

RNAZ Discussion

Ver más
Atomic_Insider Atomic_Insider 4 horas hace
It’s more than criminal, It’s a disgrace to humanity…May god burn them all in hell and crucify them all on the cross with acid

As board members and managers, we are also shareholders and are fully aware of the pain such a decision causes."

Per the DEF14A, dated 4/11/2025:
• Thomas A. Fitzgerald owns 43 shares of Common Stock.

• Philippe Calais owns 5 shares of Common Stock.

• Erik Manting and Magda Marquet each own 0 shares of Common Stock.

-Anna Moore: Co-Founder at Transcode Therapeutics
0 shares

Medarova: Co-Founder at Transcode Therapeutics.
0 shares

Michael Dudley: Co-Founder & CEO at Transcode Therapeutics.
0 shares
👍️0
Atomic_Insider Atomic_Insider 4 horas hace
The greatest achievement of management is R/S funneling the criminal funders cartel money strait in their pockets while they short the stock for bitcoin and crypto bonuses, true pioneers experts in the scam of the century of corporate america. Make no mistake ALL OF THE FECES IN MANAGEMENT ARE GOING TO JAIL FOR FRAUD
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 4 horas hace
These are the founders of the money laundering cash machine created to funnel the cash cow strait in their pockets with the criminal funders in bed with all of management

Anna Moore: Co-Founder at Transcode Therapeutics . 0 shares

Medarova CSO Co-Founder at Transcode Therapeutics. 0 shares

Michael Dudley: Co-Founder & CEO at Transcode Therapeutics. 0 shares
👍️0
Atomic_Insider Atomic_Insider 4 horas hace
The money laundering funders are all in bed with the money funneling management to short this stock dry while management funnels it all in their pockets, extra bonus in bitcoin and crypto are in play for bonuses of all the criminals involved in this scam
👍️0
Atomic_Insider Atomic_Insider 4 horas hace
Reverse Split ratio for RNAZ laundering cash cow scam machine since it went public on 07/2021 is 1,056,000 shares to one. a scam to screw retail and all shareholders hard earned money since inception to funnel it all strait in founders pockets
👍️0
Atomic_Insider Atomic_Insider 5 horas hace
Management are all going to jail for fraud next week, busted for money laundering scam since inception built to funnel the cash cow strait in there pockets while the screw the world
👍️0
Atomic_Insider Atomic_Insider 5 horas hace
Perfect you can take the voting info and slap it up Fitzgerald’s 43 shares and Calais’s 5 shares asshole with this money laundering scam machine built to funnel the cash cow machine strait in their pockets, May they all rot in hell for easter,Jail time is coming for all of management where the gorillas can rape their asshole’s night and day
👍️0
tapioca tapioca 13 horas hace
Me too. Good Friday and Markets closed, thank Christ…🙄
👍️0
Stks_Not_Toys Stks_Not_Toys 13 horas hace
I received the voting info this morning.
👍️0
Atomic_Insider Atomic_Insider 1 día hace
The money laundering scam machine is overheating and ready to blow up
👍️0
Atomic_Insider Atomic_Insider 1 día hace
Let is collapse while the criminal fraud artists in management funnels it in their pockets with the money laundering machine,
Make no mistake they are all going to jail for fraud at the highest level of corporate america
👍️0
Atomic_Insider Atomic_Insider 1 día hace
Let the hero luigi mangioni out of jail and take care of business with these low lives money laundering funneling money in their pocket criminals of the nasdaq pharmaceuticals.
👍️0
Atomic_Insider Atomic_Insider 1 día hace
We know your criminal scam fraud tricks? You did offering on Sunday midnight when retails were all set to take this to moon next day(Monday). But you thieves killed all the momentum! Now you desperately need money to fill your pockets doing another offering next day and in tandem with mm and shorts you suck our hard earned money ! This how you value your shareholders? This how you run your company, Let luigi mangioni out of jail and take care of business with these low lives money laundering criminals of the nasdaq pharmaceuticals
👍️0
Atomic_Insider Atomic_Insider 1 día hace
It’s been all planned out from inception, these crack head junkies need to be criminally charged for fraud at the highest level of corporate america,
Slap tim all in jail for fraud with 10 gorillas busting their asses open

https://www.manhattanstreetcapital.com/transcode-therapeutics-leadership
👍️0
Atomic_Insider Atomic_Insider 1 día hace
All they want is cash from the money laundering cash cow, they don’t want shares from the funneling money machine in their pockets scam of the pharmaceuticals, make no mistake these scam artists are going to jail for fraudulent activities

This is what the fraud artists had to say ***As board members and managers, we are also shareholders and are fully aware of the pain such a decision causes."

Per the DEF14A, dated 4/11/2025:
• Thomas A. Fitzgerald owns 43 shares of Common Stock.
• Philippe Calais owns 5 shares of Common Stock.
• Erik Manting and Magda Marquet each own 0 shares of Common Stock.
👍️0
Atomic_Insider Atomic_Insider 1 día hace
The company, gets cash from sharks and sharks get in return means by TCT to devaour retail till the last drop of blood dissolves away. They funnel the cash cow strait in their pockets The Company keeps going solo for as long as the above scheme could be repeated and new unexpecting retail supply would come in. The money laundering machine keep raising money by leting sharks to consume remaining retail, TCT will be forced to turn to other options, including ones that finally might benefit retail: deals, a buyout or even going BK while management fills up their pockets till the last drop till they pull the plug on all
👍️0
Tiger Money Tiger Money 1 día hace
This is criminal 
👍️0
Atomic_Insider Atomic_Insider 1 día hace
Of course they did management has no skin in the game. a money laundering scam from inception to funnel t all in their pockets
Thomas A. Fitzgerald owns 43 shares of Common Stock.
• Philippe Calais owns 5 shares of Common Stock.
Management don’t get effected with R/S!!! all they want is cash from the cash cow funneling money laundering machine that is why there is never growth to this nobel prize mi-Rna scam of the century clinical trials pharmaceuticals piece of shit
👍️0
Monksdream Monksdream 1 día hace
RNAZ, new 52 week low
👍️0
Here Today Here Today 1 día hace
If this company approves and enacts another reverse stock split, say hello to below $.10 before the split occurrs in my opinion:
Reverse Stock Splits:
On May 23, 2023, the Company effected a reverse split of the Company’s common stock, either issued and outstanding or held by the Company as treasury stock, (the “2023 Reverse Split”) previously approved by the Board and stockholders of the Company. The 2023 Reverse Split was at a ratio of one share for every 20 shares previously held with no change in the par value per share. The 2023 Reverse Split did not change the number of authorized shares of common stock. 
On January 16, 2024, the Company effected a reverse split of the Company’s common stock, either issued and outstanding or held by the Company as treasury stock, (the “January 2024 Reverse Split”) previously approved by the Board and stockholders of the Company. The January 2024 Reverse Split was at a ratio of one share for every 40 shares previously held with no change in the par value per share. The January 2024 Reverse Split did not change the number of authorized shares of common stock.
On December 4, 2024, the Company effected a reverse split of the Company’s common stock, either issued and outstanding or held by the Company as treasury stock, (the “December 2024 Reverse Split”) previously approved by the Board and stockholders of the Company. The December 2024 Reverse Split was at a ratio of one share for every 33 shares previously held with no change in the par value per share. The December 2024 Reverse Split did not change the number of authorized shares of common stock.
👍️0
Atomic_Insider Atomic_Insider 2 días hace
May everyone in Management and everyone involved in this money laundering cash cow funneling investors money in their pockets burn in hell for easter, May they rot in jail by getting rapped by multiple gorillas daily
Make no mistake all of management is going to jail for fraud and make the S.E.C make an example of them on the world markets
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 2 días hace
As for the CEO and Chairman and all of management you can take your 43 shares and 5 shares respectively and put it up your ass, Jail time is coming for you rotten souls of humanity and will make sure you all burn in hell once and for all

Per the DEF14A, dated 4/11/2025:
• Thomas A. Fitzgerald owns 43 shares of Common Stock.
• Philippe Calais owns 5 shares of Common Stock.
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Management don’t get effected with R/S!!! all they want is cash from the cash cow funneling money laundering machine that is why there is never growth to this nobel prize mi-Rna scam of the century clinical trials pharmaceuticals piece of shit
👍️0
Atomic_Insider Atomic_Insider 2 días hace
This is how fraud artists rolll, all they want is cash, they don’t want shares of this money laundering cash cow funneling machine in their pockets scam of the pharmaceuticals

As board members and managers, we are also shareholders and are fully aware of the pain such a decision causes."

Per the DEF14A, dated 4/11/2025:
• Thomas A. Fitzgerald owns 43 shares of Common Stock.
• Philippe Calais owns 5 shares of Common Stock.
• Erik Manting and Magda Marquet each own 0 shares of Common Stock.
👍️0
dinogreeves dinogreeves 2 días hace
The greatest attribute to have in this arena is common sense and if luck is on your side you can make good scores. The fact still remains as I have brought this up to this board before, if this science is groundbreaking, why sell yourself so short to toxic funding, all big players will beg to get in bed with you to make it success, all this is a wishful thinking no good dead money.
👍️0
Atomic_Insider Atomic_Insider 2 días hace
These are all the feces of the Micro Rna pharmaceuticals going to jail for fraud
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 2 días hace
100% correct, Need to put these criminals behind bars once and for all, Everyone involved in this company needs to go to jail for fraud, A planned scam since inception to defraud others by presenting a fraudulent offer and pretending that it is legitimate, Giving the mark a taste of the profits with an initial scam, gaining trust with a 'convincer' criminal like think equity to feed the victim's appetite for more,
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Jail is where they all belong for money laundering, fraudulent activities, funneling investors money in their pockets with the cash cow scam box, while rapping investors since inception
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Very desperate now that everyone knows they are the scam artists of the nobel prize mi-Rna clinical trials, They now realize they are all going to jail for fraudulent activities since inception. Scientific scam artist by profession
👍️0
dinogreeves dinogreeves 2 días hace
I agree, I was never wrong on $MULN, in-fact I was on Net Element before the merger 100,000 shares at an average of $2.80 sold everything at 10.00 former ticker was NETE before it became $MULN, it was a scam before $MULN and it is still a scam, much like RNAZ, it was a scam and still a scam and alway will be scam. You know the saying goes A leopard never changes its spots"
👍️0
Atomic_Insider Atomic_Insider 2 días hace
It’s the MULN of the nobel prize micro Rna cancer clinical trial scam of pharmaceuticals President Ceo Chairman all going to jail for fraud
👍️0
dinogreeves dinogreeves 2 días hace
This is $MULN type scam to the core, deader than dead money. Buy the crap out of $DXF tomorrow and watch it moon with 230,000 float.
👍️0
tapioca tapioca 2 días hace
Oh right, thx for the reminder, done..
👍️0
Here Today Here Today 2 días hace
Their on their knees like a $2 crack Whore begging to suck you're d¥<k for a quick fix!!!
👍️0
Here Today Here Today 2 días hace
Company getting desperate with their Open Letter to Shareholders!!!
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Time for the OTC Fitzgerald where you and Calais can reverse another 20X and funnel it all in your pockets with your V-12 money laundering machine cash cow scam box
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Chairman feces face Philippe the turd Calais has many years of experience screwing investors A seasoned professional who attempts to defraud others by presenting a fraudulent offer and pretending that it is legitimate, Giving the mark a taste of the profits with an initial scam, gaining trust with a 'convincer' to feed the victim's appetite for more, Jail time is coming for you cheat, dodger, shark, swindler, fraudster, sharper, cheater, defrauder, phony, skinner
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Every Cohort is a R/S They attempt to defraud others by presenting a fraudulent offer and pretending that it is legitimate, Giving the mark a taste of the profits with an initial scam, gaining trust with a 'convincer' think equity funder to feed the victim's appetite for more, Busted for fraud jail time coming for all of managements fraudulent activities
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Let’s breakout on the boards and let the world know of the biggest money laundering funneling in their pocket cash cow hoax of the nobel micro rna scam of the scientific community brought to you by Ceo Fitzgerald the turd and his accomplice feces face Calais Chairman of the biggest scam of the pharmaceuticals on the nasdaq, bust their asses in jail and get raped by 20 gorillas
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Everyone involved in this money laundering funneling cash cow will be jailed for fraud, The scam artists in management will get busted for fraud activities
Chairmain Calais feces face is a disgrace to humanity. A scam artist by nature, look at all the pretty faces going to get busted for fraud.
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 2 días hace
These individuals will be all jailed for fraud, The feces of the mi-rna nobel prize community, a disgrace at all levels of corporate america, A scam at the highest level of play Material misrepresentation
The falsity of the statement
False representation
These are the feces that funneled shareholder hard earned money strait in their pockets
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Who gives shit, shareholders already lost it all with these criminal money laundering funneling strait in their pocket management ,
They attempt to defraud others by presenting a fraudulent offer and pretending that it is legitimate, Giving the mark a taste of the profits with an initial scam, gaining trust with a 'convincer' funder to feed the victim's appetite for more, Jail is where they belong, behind bars so they can get rapped by 10 Gorillas for what they have accomplished
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Feces face Chairmain Philippe the turd Calais your going to jail for fraud, money laundering and funneling it in managements pockets while you run the company strait to the ground,
Philippe P. Calais, Pharm D, PhD has served as a member of our board of directors since October 2018 and was elected chairman of the board in January 2021. Dr. Calais has over 30 years of biotech and pharmaceutical industry experience both in North America and Europe, and is the President, Chief Executive Officer and Director at MatriSys Bioscience, Inc. He is Chairman of the Board of Directors of Phileas Pharma, Inc., an oligonucletide company he founded in May 2019. Previously, Dr. Calais served as the president and chief executive officer of Isarna Therapeutics B.V., a developer of oligonucleotide therapeutics in Germany, the
Netherlands and the United States from March 2012 to June 2018. Dr. Calais was a director of CohBar, Inc. (Nasdaq: CWBR) from June 2018 to June 2020 and was the company's interim CEO from December 2019 to May 2019. Prior to Isarna Therapeutics, Dr. Calais was the President and CEO of Univalor, a Canadian technology transfer organization, from April 2011 to February 2012. He is also an Economic Advisor to the French government since 2013. Dr. Calais served as Chief Executive Officer, President and Director of Ambrilia Biopharma, Inc., (TSE: AMB) from January 2008 to July 2009. He served as President Global Business of Neurochem Inc. from January 2003 to December 2007, focusing on corporate strategic positioning and company deployment. He served as Chairman of the Board of Neurochem International, a wholly owned subsidiary of Neurochem inc. (Nasdaq: NRMX) from March 2003 to
December 2007. He was an Independent Director at Marina Biotech, Inc. (OTCBB: MRNX) from January 2017 until May 2018, and its Lead Independent Director since October 2017. He served as a board member of Autotelic Inc. from June 2016 to June 2018. He served as Director of Canada's Research Based Pharmaceutical Companies from 2002 to 2011;
the Cit. des Biotechs de Laval from February 2002 to February 2012; Cognisense from December 2010 to February 2012 and Medpharmgene from January 2011 to February 2012. Dr. Calais holds a bachelor's degree in pharmacy and a Doctor of Pharmacy from the Universite Francois- Rabelais in Tours, France. We believe that Dr. Calais is qualified to serve on our board of directors due to his management experience in the pharmaceutical and biotherapeutics industries and his experience as an
executive officer and board member of several biotechnology companies.
👍️0
tw0122 tw0122 2 días hace
..Vote by April 20 for reverse split what will it be 100 to 1 ..lol.. . We now risk losing our Nasdaq listing unless we achieve a closing bid price of $1.00 or above by May 5, 2025....
👍️0
Stks_Not_Toys Stks_Not_Toys 2 días hace
click ignore - no more feces
👍️0
Atomic_Insider Atomic_Insider 2 días hace
This is the group of pharmaceutical feces in clinical trials that sabotaged all shareholders to their money laundering scheme to funnel it all in there pockets while they put all shareholders on the streets with no underwears
https://www.transcodetherapeutics.com/leadership.html
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Feces face Fitzgerald has a new partner in crime Philippe Calais Chairman and got taught how to funnel shareholders hard earned money straight in their pockets by cook all the books CFO Turd master fitzgerald.
The word is out on wall street boys and girls this is the scam of the nobel prize mi-Rna pharmaceuticals
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Shareholders want to welcome The new chairman Philippe Calais as his new position to funnel the money laundering machine strait in his pockets with the feces CEo fitzgerald and the rest of management, be prepared for jail, for you elements of fraud
Material misrepresentation
The falsity of the statement
False representation
👍️0
Atomic_Insider Atomic_Insider 2 días hace
Consequently, our board of directors has put a proposal before shareholders for a reverse stock split. As board members and managers, we are also shareholders and are fully aware of the pain such a decision causes. With our company’s future in mind, we are carrying forward this difficult decision to request your approval of the reverse stock split.

Our investment bankers advised us to take this approach now to meet the $1.00 per share or more closing bid price requirement. To do this, the reverse split needs to be approved on April 21. We believe that the reverse split approval is essential to enable us to remain listed with NASDAQ, giving us a better chance of raising the additional capital we will need to continue to advance our clinical trial program.

Obviously, should our stock close above $1.00 in the timeframe required and continues trading above $1.00, the Board does not intend to effect the split even if it has been approved.
They attempt to defraud others by presenting a fraudulent offer and pretending that it is legitimate, Giving the mark a taste of the profits with an initial scam, gaining trust with a 'convincer' to feed the victim's appetite for more,
👍️0
Atomic_Insider Atomic_Insider 2 días hace
And there you have it Tom Fitzgerald and all of management who attempts to defraud others by presenting a fraudulent offer and pretending that it is legitimate, Giving the mark a taste of the profits with an initial scam, gaining trust with a 'convincer' to feed the victim's appetite for more, Jail time is coming for you…
https://ih.advfn.com/stock-market/NASDAQ/transcode-therapeutics-RNAZ/stock-news/95856209/form-defa14a-additional-definitive-proxy-solicit
👍️0

Su Consulta Reciente

Delayed Upgrade Clock